O-0003NAPOLI-1: RANDOMIZED PHASE 3 STUDY OF MM-398 (NAL-IRI), WITH OR WITHOUT 5-FLUOROURACIL AND LEUCOVORIN, VERSUS 5-FLUOROURACIL AND LEUCOVORIN, IN METASTATIC PANCREATIC CANCER PROGRESSED ON OR FOLLOWING GEMCITABINE-BASED THERAPY
暂无分享,去创建一个
David Cunningham | G. Bodoky | D. Cunningham | E. Bayever | F. Braiteh | J. Blanc | R. Hubner | J. Siveke | G. Schwartsmann | T. Macarulla | C. Chiu | Teresa Macarulla | Andrea Wang-Gillam | Kyung-Hun Lee | D. D. Hoff | V. Moyo | C.-P. Li | A. Wang-Gillam | A. Dean | G. Jameson | K. Lee | B. Belanger | N. Dhindsa | L. Chen | Bruce Belanger | Jens T. Siveke | Gilberto Schwartsmann | Victor Moyo | D. D. Von Hoff | Fadi Braiteh | Gyorgy Bodoky | C-P Li | Andrew Peter Dean | G. S. Jameson | K Lee | J Blanc | Richard A Hubner | C-F Chiu | Navreet Dhindsa | Eliel Bayever | L Chen | L.-T. Chen